pm
Our mission is to increase the number of healthy people!
    • Main page
      • About journal
      • Articles. Working with contents
      • Edtor-in-chief
      • Editorial Council
      • Editorial Board


      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications


      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
  • Prevention of stroke and dementia in patients with arterial hypertension

    Редактор | 2017, Drugs and equipment, Practical medicine 02 (17) Current questions of diagnosis | Апрель 23, 2017

    D.I. TRUKHAN1, A.L. MAZUROV2

    1Omsk State Medical University, 12 Lenin Str., Omsk, Russian Federation, 644099

    2Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetskiy, 1 Partizan Zheleznyak Str., Krasnoyarsk, Russian Federation, 660022 

    Trukhan D.I. — D. Med. Sc., Associate Professor, Professor of the Department of Internal Diseases and Polyclinic Therapy, e-mail: [email protected]

    Davydov E.L. — D. Med. Sc., Associate Professor, Associate Professor of the Department of Propaedeutics of Internal Diseases and Therapy, professor of the Chair of internal medicine and therapy, e-mail: [email protected]

     The article deals with the issues of prevention of stroke and cognitive impairment in hypertensive patients at the stage of primary health care. The data of the study Syst-Eur (The Systolic Hypertension in Europe) clearly demonstrate the effectiveness of the dihydropyridine calcium antagonist nitrendipine in reducing the risk of stroke, cognitive impairment and dementia in patients with hypertension. The emergence of the drug nitrendipine — Nitremed® — in the Russian pharmaceutical market makes it possible to optimize the prevention of cerebrovascular disease and cognitive impairment in hypertensive patients.

    Key words: primary health care, hypertension, stroke, light and moderate cognitive impairment, dementia, prevention, nitrendipine, Nitremed®.

    Метки: 2017, A.L. MAZUROV, D.I. TRUKHAN, dementia, hypertension, light and moderate cognitive impairment, Nitremed®, nitrendipine, Practical medicine 02 (17) Current questions of diagnosis, prevention, primary health care, stroke

    ‹ Experience in the use of domestic monitor of neuromuscular block – «MNMB-DIAMANT» Improvement of transmittal blood flow and proarrhythmic markers in patients with relative coronary insufficiency under trimetazidine therapy ›
    • rus Версия на русском языке


      usa English version site


      Findloupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©